الرئيسية › دليل الباحثين › Steffen Borrmann
Steffen Borrmann
الانتماء : Kenya Medical Research Institute · KEMRI-Wellcome Trust Research Programme
- 30منشورات (انتماء كيني)
الملف البحثي
لدى Steffen Borrmann 30 منشور(ات) مفهرسة (2005–2018). تُنشر أعماله أساسًا في «PLoS ONE»، «Antimicrobial Agents and Chemotherapy» و«PLoS Medicine». أكثر مقالاته استشهادًا هو «Spread of Artemisinin Resistance in Plasmodium falciparum Malaria» (2014)، وقد استُشهد به 2205 مرة. 2 من هذه المنشورات تعود إلى آخر ثلاث سنوات من النشاط. شارك في تأليف أعماله 12 باحثًا على الأقل، منهم باحثون من مؤسسات في المملكة المتحدة، الولايات المتحدة، ألمانيا، الغابون.
هل هذا أنت؟ عرّف بأبحاثك
أنشئ ملفك على DzCademia مجانًا وأضف مقالاتك: ستظهر بسهولة أكبر على Google وفي مساعدي الذكاء الاصطناعي مثل ChatGPT، فيقرؤها ويستشهد بها عدد أكبر من الناس.
إنشاء ملفي المجاني إضافة منشوراتيالمنشورات (30)
- Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
- Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis
- Novel approaches to whole sporozoite vaccination against malaria
- Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
- A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains
- A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspots
- Dihydroartemisinin-Piperaquine vs. Artemether-Lumefantrine for First-Line Treatment of Uncomplicated Malaria in African Children: A Cost-Effectiveness Analysis
- Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya
- Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives
- PlasmoView: A Web-based Resource to Visualise Global Plasmodium falciparum Genomic Variation
- Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing
- Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast
- Population Genetic Analysis of Plasmodium falciparum Parasites Using a Customized Illumina GoldenGate Genotyping Assay
- Induction of Antimalaria Immunity by Pyrimethamine Prophylaxis during Exposure to Sporozoites Is Curtailed by Parasite Resistance
- Targeting Plasmodium liver stages: better late than never
- Pharmacokinetic and Pharmacodynamic Characteristics of a New Pediatric Formulation of Artemether-Lumefantrine in African Children with Uncomplicated Plasmodium falciparum Malaria
- Natural Immunization Against Malaria: Causal Prophylaxis with Antibiotics
- The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem®) for acute uncomplicatedPlasmodium falciparummalaria
- Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya
- In Vitro Activities of Quinine and Other Antimalarials and pfnhe Polymorphisms in Plasmodium Isolates from Kenya
- Chloroquine resistance before and after its withdrawal in Kenya
- In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in p fcrt and p fmdr1
- Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
- Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria
- In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase ofPlasmodium falciparumIsolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu Mutation
- In Vivo and In Vitro Efficacy of Amodiaquine againstPlasmodium falciparumin an Area of Continued Use of 4‐Aminoquinolines in East Africa
- Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial
- Effects of Plasmodium falciparum Parasite Population Size and Patient Age on Early and Late Parasitological Outcomes of Antimalarial Treatment in Children
- Delayed parasite elimination in human infections treated with clindamycin parallels ‘delayed death’ of Plasmodium falciparum in vitro
- SHORT REPORT: PILOTING PAPERLESS DATA ENTRY FOR CLINICAL RESEARCH IN AFRICA
مجلات النشر
- PLoS ONE × 6
- Antimicrobial Agents and Chemotherapy × 6
- PLoS Medicine × 2
- Malaria Journal × 2
- The Journal of Infectious Diseases × 2
- Vaccine × 1
المنشورات حسب السنة
- 20181
- 20171
- 20151
- 20144
- 20133
- 20121
- 20115
- 20104
- 20096
- 20082
التعاون العلمي
المؤسسات الشريكة : University of Oxford · Wellcome Trust · John Radcliffe Hospital · Boston Children's Hospital · Albert Schweitzer Hospital
بلدان المؤلفين المشاركين : المملكة المتحدة · الولايات المتحدة · ألمانيا · الغابون
المؤلفون المشاركون
- Leah Mwai
- Alexis M. Nzila
- Kevin Marsh
- Steven M. Kiara
- Philip Galula Sasi
- Mahfudh M. Bashraheil
- Judy Peshu
- Elizabeth A Juma
- Brett S Lowe
- Steven Muriithi
- Abdirahman I. Abdi
- John Okombo
البيانات البيبليوغرافية مصدرها OpenAlex (قاعدة مفتوحة).
لماذا تختارون DzCademia؟
ملفات أكاديمية ومقالات ومداخلات علمية: امنحوا أبحاثكم حضوراً عاماً منظماً. تساعد البيانات الوصفية المدمجة محركات البحث ومساعدات الذكاء الاصطناعي على التعرف على أعمالكم وفهم مراجعها.
علّق عبر Google
سجّل الدخول عبر Google للتعليق مباشرة على هذه الصفحة.